StockWatch
·
Biotechnology: Pharmaceutical Preparations
Equity OfferingApr 8, 2026, 08:16 AM

FORUM MARKETS (FRMM) Terminates At-The-Market Equity Offering Program

AI Summary

FORUM MARKETS Inc. announced on April 8, 2026, the cessation of its at-the-market (ATM) equity offering program by entering into a Second Amended and Restated Sales Agreement with its agents, Clear Street LLC and TCBI Securities, Inc. This program, initially established in August 2025, allowed the company to sell common stock from time to time. The termination signifies that FRMM will no longer utilize this specific mechanism for continuous equity issuance, potentially impacting future share dilution and the company's capital raising strategy.

Key Highlights

  • FORUM MARKETS Inc. (FRMM) entered into a Second Amended and Restated Sales Agreement on April 8, 2026.
  • The agreement ceases all sales of Common Stock under the company's existing at-the-market (ATM) offering program.
  • The ATM program was initially established on August 13, 2025, with Clear Street LLC as the sole sales agent.
  • On November 14, 2025, the program was amended to include TCBI Securities, Inc. (Texas Capital Securities) as an additional sales agent.
  • Sales under the program were conducted pursuant to the WKSI Registration Statement on Form S-3ASR (File No. 333-289811).